Related Experiment Video
Updated: Aug 1, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Thymidylate synthase with a C-terminal deletion catalyzes partial reactions but is unable to catalyze thymidylate
C W Carreras1, S C Climie, D V Santi
1Department of Pharmaceutical Chemistry, University of California, San Francisco 94143-0448.
Abstract:
The V316Am mutant of Lactobacillus casei thymidylate synthase has a single amino acid deletion at the C-terminus which abolishes catalysis of dTMP formation. However, V316Am catalyzes two partial reactions which require covalent catalysis: a CH2H4folate-dependent exchange of the 5-hydrogen of dUMP for protons in water and a thiol-dependent dehalogenation of 5-bromo- and 5-iodo-dUMP. These reactions proceed with kcat and Km values similar to those of the wild-type TS-catalyzed reactions. dUMP, dTMP, and FdUMP are competitive inhibitors of the debromination reaction with Ki values similar to those obtained with wild-type enzyme. These results show that removal of the terminal valine does not alter the ability of the enzyme to bind to or form covalent bonds with nucleotide ligands. V316Am also forms a covalent ternary complex with FdUMP and CH2H4folate. However, the affinity of the TS-FdUMP complex for the cofactor is reduced, and the rate of covalent ternary complex formation and its stability are significantly lower than with wild-type TS. These results allow us to place the major defects of the mutation on steps that occur subsequent to initial CH2H4folate binding.
Insights
The Lactobacillus casei thymidylate synthase V316Am mutant, lacking a C-terminal valine, cannot form dTMP but retains partial catalytic activity. This indicates the mutation affects later steps in the reaction mechanism, not initial cofactor binding.
Area of Science:
- Enzymology
- Biochemistry
- Molecular Biology
Background:
- Lactobacillus casei thymidylate synthase (TS) is crucial for DNA synthesis.
- Mutations can reveal insights into enzyme mechanisms and active site residues.
Purpose of the Study:
- To investigate the catalytic mechanism of the V316Am mutant of Lactobacillus casei TS.
- To determine the role of the C-terminal valine in TS catalysis and substrate binding.
Main Methods:
- Enzyme kinetics assays were performed on the V316Am mutant.
- Catalytic activity, inhibition patterns, and complex formation were analyzed.
- Comparison with wild-type TS was conducted.
Main Results:
- V316Am lacks dTMP formation activity but retains partial reactions: 5-hydrogen exchange and dehalogenation.
- Similar kcat and Km values for partial reactions suggest intact substrate binding and covalent catalysis.
- Competitive inhibition by dUMP, dTMP, and FdUMP indicates preserved nucleotide binding.
- V316Am forms a covalent ternary complex, but with reduced cofactor affinity and stability.
Conclusions:
- The C-terminal valine is not essential for substrate binding or initial covalent bond formation.
- The V316Am mutation primarily affects steps subsequent to cofactor binding in the TS catalytic cycle.
More Related Videos
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
09:31PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
Published on: September 26, 2020
Related Concept Videos
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
tRNA Activation
ATP Synthase: Mechanism
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Biosynthesis of Nucleic Acids